SMC4 and prostate carcinoma: Furthermore, our examination of the Oncomine prostate cancer datasets revealed a noteworthy elevation of SMC4 mRNA expression in metastatic prostate cancer compared to that in primary tumors, suggesting an ongoing contribution to the progression of metastasis (Figure 1D–F).